Induction of blood vessel formation through administration of polynucleotides encoding sphingosine kinases

Details for Australian Patent Application No. 2005242200 (hide)

Owner Novartis AG

Inventors Liau, Gene; Su, Joseph; Stefansson, Steingrimur

Agent Davies Collison Cave

Pub. Number AU-B-2005242200

Parent 2002224771

Filing date 9 December 2005

Wipo publication date 5 January 2006

Acceptance publication date 24 April 2008

International Classifications

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

5 January 2006 Application Open to Public Inspection

  Published as AU-B-2005242200

5 January 2006 Complete Application Filed

24 April 2008 Application Accepted

  Published as AU-B-2005242200

21 August 2008 Standard Patent Sealed

29 April 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005242201-Gypsum compositions with enhanced resistance to permanent deformation

2005242199-Trailer